Takeda Pharmaceutical Company Limited Liabilities Arising From Financing Activities
Takeda Pharmaceutical Company Limited (TKPHF) had Liabilities Arising From Financing Activities of JPY 5.02 trillion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:LiabilitiesArisingFromFinancingActivities · last filed 2025-06-25
- 2025-03-31: Liabilities Arising From Financing Activities 5.02T JPY.
- 2024-03-31: Liabilities Arising From Financing Activities 5.37T JPY.
- 2023-03-31: Liabilities Arising From Financing Activities 4.82T JPY.
- 2022-03-31: Liabilities Arising From Financing Activities 4.80T JPY.
| Period end | Liabilities Arising From Financing Activities | Liabilities Arising From Financing Activities as first filed |
|---|---|---|
| 2025-03-31 | 5.02T JPY 20-F · filed 2025-06-25 | |
| 2024-03-31 | 5.37T JPY 20-F · filed 2025-06-25 | |
| 2023-03-31 | 4.82T JPY 20-F · filed 2025-06-25 | |
| 2022-03-31 | 4.80T JPY 20-F · filed 2024-06-26 | |
| 2021-03-31 | 5.13T JPY 20-F · filed 2023-06-28 | |
| 2020-03-31 | 5.46T JPY 20-F · filed 2022-06-29 | |
| 2019-04-01 | 6.15T JPY 20-F · filed 2020-06-24 | |
| 2019-03-31 | 6.15T JPY 20-F · filed 2021-06-29 | 5.93T JPY 20-F · filed 2019-06-27 |
| 2018-04-01 | 1.04T JPY 20-F · filed 2020-06-24 | |
| 2018-03-31 | 1.04T JPY 20-F · filed 2019-06-27 | |
| 2017-03-31 | 1.20T JPY 20-F · filed 2019-06-27 |